Cipla, founded in 1935, is a leading global pharmaceutical company headquartered in India, operating primarily in the healthcare sector. The company focuses on the development, manufacturing, and marketing of a wide range of medicines, including generics, active pharmaceutical ingredients (APIs), and proprietary products. Cipla is renowned for its affordable and high-quality medications, particularly in the fields of respiratory, antiretroviral, and cardiovascular treatments. With a strong presence in over 80 countries, Cipla serves both consumers and businesses, leveraging its extensive distribution network to enhance healthcare accessibility worldwide. The company plays a vital role in the pharmaceutical industry by prioritising innovation and patient needs.